Impaired tumor immune response in metastatic tumors is a selective pressure for neutral evolution in CRC cases.
Sakimura S, Nagayama S, Fukunaga M, Hu Q, Kitagawa A, Kobayashi Y, Hasegawa T, Noda M, Kouyama Y, Shimizu D, Saito T, Niida A, Tsuruda Y, Otsu H, Matsumoto Y, Uchida H, Masuda T, Sugimachi K, Sasaki S, Yamada K, Takahashi K, Innan H, Suzuki Y, Nakamura H, Totoki Y, Mizuno S, Ohshima M, Shibata T, Mimori K.
Sakimura S, et al. Among authors: tsuruda y.
PLoS Genet. 2021 Jan 21;17(1):e1009113. doi: 10.1371/journal.pgen.1009113. eCollection 2021 Jan.
PLoS Genet. 2021.
PMID: 33476333
Free PMC article.